Related Experiment Video
Updated: Dec 1, 2025
15:18
Making MR Imaging Child's Play - Pediatric Neuroimaging Protocol, Guidelines and Procedure
Published on: July 30, 2009
18.5K
Overmedicalization in Children with Medical Complexity.
Pediatric Annals
|November 10, 2020
Summary
Children with medical complexity (CMC) face high risks of overmedicalization (OM) due to frequent healthcare interactions. This review offers primary providers an algorithm and multidisciplinary approach to identify and manage OM in CMC.
Area of Science:
- Pediatric Healthcare
- Medical Complexity
- Overmedicalization
Background:
- Children with medical complexity (CMC) have extensive healthcare system exposure.
- Reliance on family caregivers is high for CMC.
- These factors increase the risk of overmedicalization (OM) in CMC.
Purpose of the Study:
- To review risk factors for OM in CMC.
- To present an algorithm for primary providers to recognize and address OM.
- To discuss challenges related to suspected medical child abuse causing OM.
Main Methods:
- Literature review of risk factors for OM in CMC.
- Development of a clinical algorithm for OM identification.
- Discussion of multidisciplinary team involvement and child advocacy.
Main Results:
- Identified key risk factors contributing to OM in CMC.
- Proposed a practical algorithm for primary care providers.
- Highlighted the importance of a multidisciplinary approach.
Conclusions:
- A structured approach and multidisciplinary team are crucial for managing OM in CMC.
- Primary providers can utilize the algorithm to mitigate OM risks.
- Special considerations are needed when medical child abuse is suspected.
Related Concept Videos
01:15Methods of Documentation VI: Case Management Model
748
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
748
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
99
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
99
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
120
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
120
01:29Drug Dosing: Infants and Children
121
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
121
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
130
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
130
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
146
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
146